<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anc Sci Life</journal-id><journal-id journal-id-type="iso-abbrev">Anc Sci Life</journal-id><journal-id journal-id-type="publisher-id">ASL</journal-id><journal-title-group><journal-title>Ancient Science of Life</journal-title></journal-title-group><issn pub-type="ppub">0257-7941</issn><issn pub-type="epub">2249-9547</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3800929</article-id><article-id pub-id-type="publisher-id">ASL-32-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>OA01.05. Role of prabhakara vati and lekhana basti treatment in the management of coronary artery disease (Hridroga)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Amit Kumar</given-names><suffix>Dr.</suffix></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Joshi</surname><given-names>Ram Kishor</given-names><suffix>Dr.</suffix></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Sashi Mohan</given-names><suffix>Prof.</suffix></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Ajay Kumar</given-names><suffix>Prof.</suffix></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><collab><italic>From</italic> 5th World Ayurveda Congress 2012 Bhopal, Madhya Pradesh, India. 7-10 Dec 2012</collab><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff id="aff1"><label>1</label>Deptt Of Kayachikitsa (Medicine), National Institute of Ayurveda, Jaipur - 302 002, Rajasthan, India</aff><aff id="aff2"><label>2</label>Department of Cardiology, S.M.S. Hospital, Jaipur-302002</aff><aff id="aff3"/><pub-date pub-type="ppub"><month>12</month><year>2012</year></pub-date><volume>32</volume><issue>Suppl 1</issue><fpage>S5</fpage><lpage>S5</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2012 Amit Kumar Sharma; licensee Ancient Science of Life.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</uri>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Purpose:</title><p>The present study was conducted on 30 clinically diagnosed and confirmed patients of Coronary Artery Disease (C.A.D.). Patients having C.A.D. with specific conditions were not registered. The study was conducted with an objective of evaluating the role of Prabhakara Vati and Lekhana Basti in the management of C.A.D. on various scientific parameters.</p></sec><sec id="st2"><title>Method:</title><p>30 patients were randomly divided into three groups. It was a randomised, comparative, open ended, pre and post design, clinical trial. Out of the three groups, 10 patients were administered Tab. Dilzem 30 mg TDS for one month, 10 patients of second group were administered Prabhakara Vati 500 mg (two tablets) bd for one month and 10 patients were administered Lekhana Basti (for 15 days) along with Prabhakara Vati 500 mg (two tablets) bd for one month.</p></sec><sec id="st3"><title>Result:</title><p>During present trial it was observed that there was significant improvement in clinical manifestations of stable angina after the therapy with Prabhakara Vati and Lekhana Basti. The level of S. Cholesterol, L.D.L., V.L.D.L. and Serum Triglycerides decreased and the level of H.D.L. increased considerably after the therapy.</p></sec><sec id="st4"><title>Conclusion:</title><p>Prabhakara Vati and Lekhana Basti possesses potent antianginal and cardio protective activities and it can be used effectively in the management/to slow down the progress of pathogenesis of atherosclerosis leading to various Hridrogas (C.A.D.) specially stable angina.</p></sec></abstract></article-meta></front></article>